Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by fdfd12 on Feb 08, 2017 8:41am

CXR

It survival depends on only one thing.

Can the cash it has and will earn in the future be enough to pay their big debt.

If yes, then stock will go to $100 in time.
If no, then bankruptcy.

That is the bottom line.

Today TD cuts to $1 from $2.5 so we will drop at the open.
If the market senses that CXR will survive in the long run. We will bounce back today or tomorrow.
If not, then we may have a $1 drop to $2.50
Comment by DeathPool on Feb 08, 2017 9:01am
You are right fdfd.  And if Mr. Herlot/Lumber are wondering where all the shorts have been, well... the pump and dump is how it works with cxrx and the rich keep getting richer.  You will notice that in the most recent press release that stated they paid out Cinven, no "cash on hand" figure was reitereated as in other PR's. Don't say you weren't warned.   And ...more  
Comment by DeathPool on Feb 08, 2017 9:10am
fdfd, I hope you were sarcastic about the stock being $100 in no time.  Paying debt makes it survive, but they are no longer able to make acquisitions nor does it change the fact that their drug portfolio is declining.  The growth story is over.   Sell into what is the last pump and move on from this trainwreck.   THRE HAS BEEN NO INSIDER BUYING....   (Source:  Sedi ...more  
Comment by fdfd12 on Feb 08, 2017 9:20am
I said $100 in time, not in NO TIME. If the debt is paid and they continue doing $1 each quarter, then things will look good. They don't have to increase their prices. Keep the prices where they are and get rid of the debt and it is close to $100.
Comment by MrHulot on Feb 08, 2017 9:37am
Oh, Look who’s back with a lower open. Brave DeathStool/Sir Robin
Comment by rad10 on Feb 08, 2017 9:02am
Yes that is the reality of the situation FDFD.  Key metric will be erosion of EBITDA at the next release.   No insider buying, no guidance and no unexpected updates or news releases.......... The speculation on this BB is awesome entertainment with talk of dividends etc.  Here is a way to play the company - 9% yield on a secured note trading around 85 cents on the dollar for an ...more  
Comment by knowsnothing on Feb 08, 2017 9:10am
Anyone has the link for td report ? funny timing to release the report....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities